Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 257-265

  Perrotte, Paul ^a   Matsumoto, Takashi ^a   Inoue, Keiji ^a   Kuniyasu, Hiroki ^a   Eve, Beryl Y ^a   Hicklin, Daniel J ^b   Radinsky, Robert ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 8; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; CANCER INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NUDE MOUSE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-8; LYMPHOKINES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROCIRCULATION; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032972944     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Folkman, J. Clinical application of research or angiogenesis. N. Engl. J. Med., 33: 1757-1763, 1995.
2. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
3. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
4. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
5. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-361, 1994.
6. O'Brien, T. S., Smith, K., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br. J. Urol., 76: 311-314, 1995.
7. Simoneau, A. R., and Jones, P. A. Bladder cancer: the molecular progression to invasive disease. World J. Urol., 12: 89-95, 1994.
8. Chow, N. H., Tsai, T. S., Lin, S. N., Chan, S. H., and Tang, M. J. Reappraisal of the biological role of epidermal growth factor receptor in transitional cell carcinoma. Eur. Urol., 24: 140-143, 1993.
9. Messing, E. M. Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors. Semin. Surg. Oncol., 8: 285-292, 1992.
10. Gleave, M. E., Hsieh, J. T., Wu, H. C., Hong, S. J., Zhau, H. E., Guthrie, P. D., and Chung, L. W. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res., 53: 5300-5307, 1993.
11. Wood, D. P., Jr., Fair, W. R., and Chaganti, R. S. K. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J. Urol., 147: 274-277, 1992.
12. Sauter, G., Haley, J., Chew, K., Kerschmann, R., Moore, D., Carroll, P., Moch, H., Gudat, F., Mihatsch, M. J., and Waldman, F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int. J. Cancer. 57: 508-514, 1994.
13. Nguyen, P. L., Swanson, P. E., Jaszcz, W., Aeppli, D. M., Zhang, G., Singleton, T. P., Ward, S., Dykoski, D., Harvey, J., and Niehans, G. A. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am. J. Clin. Pathol., 101: 166-176. 1994.
14. Neal, D. E., Marsh, E., Bennett, M. K., Abel, P. D., Hall, R. R., Sainsbury, J. R., and Harris, A. L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet, 1: 366-368, 1985.
15. Neal, D. E., Sharples, L., Smith, K., Fennelly, J., Hall, R. R., and Harris, A. The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer (Phila.), 65: 1619-1625, 1990.
16. Chow, N. H., Liu, H. S., Lee, E. I., Chang, C. J., Chan, S. H., Cheng, H. L., Tzai, T. S., and Lin, J. S. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res., 17: 1293-1296, 1997.
17. Petit, A. M. V., Rak, J., Hung, W. C., Rockwell, P., Goldstein, N., Fendly, B., and Kerbel, R. S. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol., 151: 1523-1530, 1997.
18. Masui, H., Kawamoto, T., Sato, J. D., Wolf, B., Sato, G., and Mendelsohn, J. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 44: 1002-1007, 1984.
19. Radinsky, R., Risin, S., Fan, D., Dong, Z., Bielenberg, D., Bucana, C. D., and Fidler, I. J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res., 1: 19-31, 1995.
20. Dinney, C. P. N., Parker, C., Dong, A., Fan, D., Eve, B. Y., Bucana, C., and Radinsky, R. Therapy of human transitional cell carcinoma of the bladder by oral administration of epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide. Clin. Cancer Res., 3: 161-168, 1997.
21. Fan, Z., Masui, H., Atlas, I., and Mendelsohn, J. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 of anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res., 53: 4322-4238, 1993.
22. Goldstein, N. I., Prewet, M., Zuklys, K., Rockwell, P., and Mendelsohn, J. Biological efficacity of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995.
23. Rak, J., and Kerbel, R. S. Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls. Cancer Metastasis Rev., 15: 231-236, 1996.
24. Folkman, J. Fighting cancer by attacking its blood supply. Sci. Am., 275: 150-154, 1996.
25. Dinney, C. P., Fishbeck, R., Singh, R., Eve, B., Pathak, S., Brown, S. N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J., and Killion, J. J. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 154: 1532-1538, 1995.
26. Radinsky, R., Kraemer, P. M., Raines, M. A., Kung, H. J., and Culp, L. A. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Proc. Natl. Acad. Sci., USA, 84: 5143-5147, 1987.
27. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsburn, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
28. Berse, B., Brown, L. F., Van der Water, L., Dvorak, H. F., and Singer, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
29. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF by interleukin-1 and tumor necrosis factor. J. Exp. Med., 167: 1883-1893, 1988.
30. Perrotte, P., Bielenberg, D., Eve, Y. B., and Dinney, C. P. N. Organ-specific angiogenesis and metastasis of human bladder cancer growing in athymic nude mice. Mol. Urol., 1: 299-307, 1998.
31. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast cancer. N. Engl. J. Med., 324: 1-8, 1991.
32. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943. 1993.
33. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582. 1997.
34. Benjamin, L. E., and Keshet, E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA, 94: 8761-8766. 1997.
35. Ezekowitz, R. A., Mulliken, J. B., and Folkman, J. Interferon α-2a therapy for life threatening hemangiomas of infancy. N. Engl. J. Med., 326: 1456-1463, 1992.
36. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
37. Gutman, M., Singh, R. K., Xie, K., Bucana, C. D., and Fidler, I. J. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res., 55: 2470-2475, 1995.
38. Maher, P. A. Modulation of the epidermal growth factor receptor by basic fibroblast growth factor. J. Cell. Physiol., 154: 350-358, 1993.
39. Mothe, I., Ballotti, R., Tartare, S., Kowalski-Chauvel, A., and van Obberghen, E. Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor. Mol. Biol. Cell. 4: 737-746, 1993.
40. Link, P., and Freiha, F. S. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology, 37: 189-192, 1991.
41. Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., and Bowtell, D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSosl. Nature (Lond.), 363: 83-85, 1993.
42. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogene up-regulates VEGF/ VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
43. Kizaka-Kondoh, S., Sato, K., Tamura, K., Nojima, H., and Okayama, H. Raf-1 protein kinase is an integral component of the oncogenic signal cascade shared by epidermal growth factor and platelet-derived growth factor. Mol. Cell. Biol., 12: 5078-5086, 1992.
44. Chung, L. W. Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation. Semin. Cancer Biol., 4: 183-192, 1993.
45. Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4: 121-133, 1993.
46. Xie, H., Turner, T., Wang, M. H., Singh, R. K., Siegal, G. P., and Wells, A. In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin. Exp. Metastasis, 13: 407-419, 1995.
47. Ciardiello, F., Damiano, V., Bianco, R., Bianco, C., Fontanini, G., DeLaurentiis, M., DePlacido, S., Mendelsohn, J., Bianco, A. R., and Tortora, G. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J. Natl. Cancer Inst., 88: 1770-1776, 1996.